Identifying adverse childhood experiences in pediatrics to prevent chronic health conditions

Andrew J Barnes1, Bruno J Anthony2, Canan Karatekin3

  • 1Department of Pediatrics, University of Minnesota, St Paul, MN, USA. drbarnes@umn.edu.

Pediatric Research
|October 18, 2019
PubMed

Insights

Adverse childhood experiences (ACEs) significantly impact lifelong health, yet routine screening in pediatric care is lacking. This review explores effective methods for identifying ACEs and mitigating their toxic stress effects.

Area of Science:

  • Pediatric Health
  • Public Health
  • Toxic Stress Research

Background:

  • Over 40% of US youth experience adverse childhood experiences (ACEs).
  • ACEs have cumulative, detrimental effects on long-term health.
  • Current primary care practices lack routine ACEs screening and biomarkers for toxic stress.

Purpose of the Study:

  • To clarify the rationale, target population, timing, and methods for identifying ACEs in pediatric clinical settings.
  • To review evidence supporting ACEs identification in primary care.
  • To address barriers and recommend future directions for ACEs screening and prevention.

Main Methods:

  • Systematic review of evidence on ACEs identification in pediatric care.
  • Analysis of screening instrument efficacy and accuracy.
  • Discussion of current trends, barriers, and policy implications.

Main Results:

  • Significant evidence supports the need for ACEs identification due to lifelong health impacts.
  • Existing screening tools show variable efficacy and accuracy.
  • Lack of consensus and practical barriers hinder routine implementation.

Conclusions:

  • Standardized ACEs screening is crucial for preventing long-term health consequences of toxic stress.
  • Further research and policy changes are needed to integrate ACEs identification into pediatric practice.
  • Early identification and intervention can mitigate the adverse health effects of ACEs.

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
696
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.8K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
163
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
210
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
184
Conduct Disorder01:28

Conduct Disorder

Conduct disorder is a complex mental health diagnosis characterized by a repetitive and persistent pattern of behavior that violates societal norms, the rights of others, or age-appropriate rules. The diagnostic criteria for conduct disorder require the presence of at least three problematic behaviors within the past 12 months, with at least one occurring in the past six months. These behaviors are grouped into four categories: aggression toward people and animals; destruction of property;...
435